888 filings
Page 7 of 45
10-Q
2021 Q3
ABUS
Arbutus Biopharma Corp
Quarterly report
4 Nov 21
4:07pm
8-K
ABUS
Arbutus Biopharma Corp
4 Nov 21
Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:31am
4
ROIV
Roivant Sciences Ltd
20 Oct 21
Change in insider ownership
5:14pm
SC 13D/A
ROIV
Roivant Sciences Ltd
20 Oct 21
Arbutus Biopharma / Roivant Sciences ownership change
5:13pm
424B5
ABUS
Arbutus Biopharma Corp
8 Oct 21
Prospectus supplement for primary offering
4:19pm
8-K
ABUS
Arbutus Biopharma Corp
8 Oct 21
Other Events
4:02pm
S-8
ABUS
Arbutus Biopharma Corp
5 Aug 21
Registration of securities for employees
4:30pm
10-Q
2021 Q2
ABUS
Arbutus Biopharma Corp
Quarterly report
5 Aug 21
4:13pm
8-K
ABUS
Arbutus Biopharma Corp
5 Aug 21
Arbutus Reports Second Quarter 2021 Financial Results and Provides Corporate Update
7:31am
8-K
ABUS
Arbutus Biopharma Corp
14 Jul 21
Other Events
7:00am
8-K
ABUS
Arbutus Biopharma Corp
7 Jul 21
Other Events
7:02am
8-K
ABUS
Arbutus Biopharma Corp
6 Jul 21
Other Events
7:02am
8-K
ABUS
Arbutus Biopharma Corp
29 Jun 21
Other Events
7:02am
8-K
ABUS
Arbutus Biopharma Corp
28 Jun 21
AB-729, dosed at 60 mg every 8 weeks, achieved a mean HBsAg decline of -1.87 log10 IU/mL at week 44, comparable to 60 mg dosed every 4 weeks
8:00am
4
ABUS
Arbutus Biopharma Corp
7 Jun 21
Arbutus Biopharma / DANIEL D BURGESS ownership change
4:25pm
4
ABUS
Arbutus Biopharma Corp
7 Jun 21
Arbutus Biopharma / RICHARD C HENRIQUES JR ownership change
4:25pm
4
ABUS
Arbutus Biopharma Corp
7 Jun 21
Arbutus Biopharma / James R Meyers ownership change
4:25pm
4
ABUS
Arbutus Biopharma Corp
7 Jun 21
Arbutus Biopharma / KEITH S MANCHESTER ownership change
4:24pm
4
Cheng Andrew
7 Jun 21
Arbutus Biopharma / Andrew Cheng ownership change
4:24pm
4
Torti Frank
7 Jun 21
Arbutus Biopharma / Frank Torti ownership change
4:24pm